Tema Cardiovascular and Metabolics ETF (HRTS) Holdings $28.02 +0.58 (+2.11%) As of 04/23/2025 01:42 PM Eastern Add Compare Share Share Holdings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Top 46 HRTS HoldingsRankCompanyCurrent PriceWeightShares Held1LLYEli Lilly and Company$830.57+0.4%9.94%6,9852UNHUnitedHealth Group$428.25+0.3%7.17%6,6133AstraZeneca PLCN/A4.18%16,1094Novo Nordisk A/SN/A4.08%32,6605BBIOBridgeBio Pharma$35.29+3.3%4.03%68,2906ABTAbbott Laboratories$129.83-1.4%4.01%16,5107RHHBYRoche$39.14+0.4%3.74%53,1748VRTXVertex Pharmaceuticals$492.42+0.4%3.65%3,9439GILDGilead Sciences$106.43+0.9%3.20%15,81010MDTMedtronic$83.75+0.5%3.10%19,301 Get the Latest News and Ratings for HRTS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tema Cardiovascular and Metabolics ETF and its competitors with MarketBeat's FREE daily newsletter. 11BSXBoston Scientific$99.01+4.2%3.06%17,23812Novartis AGN/A3.06%14,93013TMOThermo Fisher Scientific$432.31-0.6%2.87%3,49714MRKMerck & Co., Inc.$78.73-0.3%2.65%17,09915BMYBristol-Myers Squibb$48.50-2.6%2.53%24,31416CRNXCrinetics Pharmaceuticals$32.37+3.5%2.46%49,08317ABBVAbbVie$177.28+2.0%2.27%6,60518Chugai Pharmaceutical Co., Ltd.N/A2.22%25,30119CYTKCytokinetics$38.00+0.5%2.09%30,85020EWEdwards Lifesciences$70.33-0.4%2.06%15,66321REGNRegeneron Pharmaceuticals$587.85+0.4%1.99%1,82522DHRDanaher$196.52+2.3%1.93%5,64523MCKMcKesson$692.25-0.4%1.92%1,49724PODDInsulet$246.49+1.0%1.90%3,91425ALNYAlnylam Pharmaceuticals$241.97+2.2%1.87%4,26226AMGNAmgen$277.91-0.2%1.86%3,38427ASNDAscendis Pharma A/S$158.14-0.6%1.56%5,78728DXCMDexCom$67.20+1.3%1.47%12,34729MDGLMadrigal Pharmaceuticals$308.79+2.0%1.28%2,15730MREOMereo BioPharma Group$2.56+2.4%1.28%370,02631MASIMasimo$157.93+3.9%1.22%4,30132INSMInsmed$70.80-0.6%1.11%8,69733Zealand Pharma A/SN/A0.94%7,40834First American Treasury Obligations FundN/A0.85%434,05335MIRMMirum Pharmaceuticals$39.62+0.5%0.83%10,82736IONSIonis Pharmaceuticals$29.10+0.2%0.80%15,92137WSTWest Pharmaceutical Services$217.48+1.1%0.80%2,14838AKROAkero Therapeutics$39.65+3.0%0.74%11,15139VKTXViking Therapeutics$25.84+1.4%0.71%18,20840GPCRStructure Therapeutics$23.32+1.2%0.59%21,380Gold Hits New Highs as Global Markets Spiral (Ad)When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. Now… as new tariffs take effect, gold is breaking records again. You've hopefully already seen this in action… but gold is surpassing $3,000 per ounce for the first time EVER.Go Here to Learn What's Happening and How to Prepare >>41ARWRArrowhead Pharmaceuticals$13.01+5.3%0.55%28,29842Gubra A/SN/A0.46%4,01843RCKTRocket Pharmaceuticals$7.14+2.4%0.33%34,89444DEPOSITS WITH BROKER FOR SHORT POSITIONSN/A0.24%179,814,70545NTLAIntellia Therapeutics$8.11-2.5%0.22%17,84846MTSRMetsera$23.58+8.8%0.16%5,909 Geographic ExposureUnited States82.1%Denmark4.4%United Kingdom4.0%Switzerland3.1%Ireland3.0%Japan2.8%Currency ExposureUSD85.1%DKK4.8%GBP4.0%CHF3.1%JPY2.8%Sector ExposureHealth Care95.3%Consumer Discretionary3.6%Industry ExposureBiotechnology61.8%Health Care Equipment & Supplies22.3%Health Care Providers & Services5.2%Pharmaceuticals4.0%Textiles, Apparel & Luxury Goods3.6%Health Care Technology1.9%SubIndustry ExposureBiotechnology56.3%Health Care Equipment12.6%Life Sciences Tools & Services8.9%Pharmaceuticals7.8%Managed Health Care5.2%Apparel, Accessories & Luxury Goods3.6%Health Care Distributors1.9%Health Care Supplies0.9%Coupon Exposure4-60.8%Maturity Exposure15-200.8% Related Companies and Tools Related Companies Global X Aging Population ETF Portfolio Companies Tradr 2X Short Innovation Daily ETF Portfolio Companies Global X U.S. Electrification ETF Portfolio Companies SPDR Galaxy Hedged Digital Asset Ecosystem ETF Portfolio Companies Tradr 2X Long Innovation ETF Portfolio Companies Fidelity Disruptive Communications ETF Portfolio Companies Fidelity Disruptive Medicine ETF Portfolio Companies Global X Genomics & Biotechnology ETF Portfolio Companies Procure Space ETF Portfolio Companies Fidelity Disruptive Finance ETF Portfolio Companies This page (NASDAQ:HRTS) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Exact July Date the AI Correction Will End?AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...Brownstone Research | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Cardiovascular and Metabolics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Cardiovascular and Metabolics ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HRTS Stock Free HRTS Stock Alerts